Suppr超能文献

单纯使用年度粪便免疫化学试验筛查与单次结肠镜检查相结合对降低结直肠癌死亡率的效果:日本秋田人群为基础的结肠镜筛查试验(秋田人群结肠镜筛查试验)。

Efficacy of screening using annual fecal immunochemical test alone versus combined with one-time colonoscopy in reducing colorectal cancer mortality: the Akita Japan population-based colonoscopy screening trial (Akita pop-colon trial).

机构信息

Aomori Prefectural Central Hospital, 2-1-1 Higashi-Tsukurimichi, Aomori, 030-8553, Japan.

Division of Medical Support and Partnership, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan.

出版信息

Int J Colorectal Dis. 2020 May;35(5):933-939. doi: 10.1007/s00384-020-03518-w. Epub 2020 Feb 7.

Abstract

PURPOSE

Screening programs using fecal occult blood testing help reduce mortality from colorectal cancer (CRC). Colonoscopy and colonoscopy combined with fecal occult blood testing are considered alternatives with higher sensitivity than fecal tests; however, to our knowledge, randomized controlled trials (RCTs) providing such evidence have not been reported. Therefore, this study aimed to compare screening using the fecal immunochemical test (FIT) combined with colonoscopy and FIT alone to evaluate the efficacy of colonoscopy screening in reducing CRC mortality.

METHODS

This multicenter, prospective, randomized, controlled study included average-risk individuals for CRC living in the study areas and aged 40-74 years. The exclusion criteria were history of CRC, hereditary non-polyposis CRC, familial adenomatous polyposis, inflammatory bowel diseases, history of cancer other than CRC within the past 5 years, and not expected to survive from comorbid illness. The intervention group underwent one-time colonoscopy and annual FIT, while the control group underwent annual FIT. The primary endpoint was mortality from CRC, while the secondary endpoints were cumulative incidence of invasive CRC, advanced CRC (invasion into the muscle layer or deeper), invasive cancer and screening sensitivities and specificities of invasive CRC, whole CRC, advanced neoplasia, and prevalence of adverse events. The intervention and control groups comprised 4876 and 4875 participants, respectively.

CONCLUSION

This explanatory RCT evaluated the efficacy of colonoscopy screening by valid statistical inference based on randomization. Data on adverse events from this kind of screening are necessary when considering implementation of future screening programs.

TRIAL REGISTRATION

UMIN Clinical Trials Registry, number UMIN000001980.

摘要

目的

粪便潜血检测的筛查项目有助于降低结直肠癌(CRC)的死亡率。结肠镜检查和结肠镜检查联合粪便潜血检测被认为是比粪便检测具有更高敏感性的替代方法;然而,据我们所知,尚未有报告提供此类证据的随机对照试验(RCT)。因此,本研究旨在比较使用粪便免疫化学试验(FIT)联合结肠镜检查和单独使用 FIT 进行筛查,以评估结肠镜检查筛查在降低 CRC 死亡率方面的效果。

方法

这是一项多中心、前瞻性、随机、对照研究,纳入居住在研究区域且年龄在 40-74 岁的 CRC 平均风险个体。排除标准为 CRC 病史、遗传性非息肉病 CRC、家族性腺瘤性息肉病、炎症性肠病、过去 5 年内除 CRC 以外的其他癌症史以及因合并疾病而预期无法存活。干预组接受一次性结肠镜检查和每年一次的 FIT,而对照组仅接受每年一次的 FIT。主要终点是 CRC 死亡率,次要终点是侵袭性 CRC 的累积发生率、进展期 CRC(侵犯肌肉层或更深)、侵袭性癌症以及侵袭性 CRC、全结直肠癌、进展期肿瘤和不良事件发生率的筛查敏感性和特异性。干预组和对照组分别纳入 4876 名和 4875 名参与者。

结论

本解释性 RCT 通过基于随机分组的有效统计推断评估了结肠镜检查筛查的效果。在考虑实施未来的筛查计划时,需要此类筛查的不良事件数据。

试验注册

UMIN 临床试验注册,编号 UMIN000001980。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验